United States Government Publishing Office publisher pbl distributor dst United States Congress Senate author aut Government Organization text government publication eng CHRG Congressional Committee Materials 114_senate_hearings legislative 2022-10-21 https://www.govinfo.gov/app/details/CHRG-114shrg48705 https://www.govinfo.gov/content/pkg/CHRG-114shrg48705/html/CHRG-114shrg48705.htm https://www.govinfo.gov/content/pkg/CHRG-114shrg48705/pdf/CHRG-114shrg48705.pdf U.S. Government Publishing Office 2016-04-27 monographic deposited born digital 2 p. Y 4.AG 4: https://www.govinfo.gov/app/details/CHRG-114shrg48705 P0b002ee1b7a2d466 001200513 f:48705.txt DGPO 2022-10-21 2022-10-22 CHRG-114shrg48705 machine generated eng fdlp SHRG CHRG-114shrg48705 G SENATE 114 2 846 2016-04-27 S. Hrg. 114-846 [ERRATA] VALEANT PHARMACEUTICALS' BUSINESS MODEL: THE REPERCUSSIONS FOR PATIENTS AND THE HEALTH CARE SYSTEM ERRATA CHRG-114shrg48705 1 VALEANT PHARMACEUTICALS' BUSINESS MODEL: THE REPERCUSSIONS FOR PATIENTS AND THE HEALTH CARE SYSTEM false 48-705 Special Committee on Aging Aging (Special) false true United States Congress Senate Special Committee on Aging associated name asn Government Organization Serial No. 114-24